Back to List View Graph View

Monoclonal antibody

A monoclonal antibody (mAb) is an antibody preparation derived from a single B-cell clone or engineered to recognize one defined antigenic determinant with high specificity.

Where the papers sit

30 papers from the last 6 months study monoclonal antibody directly · updated from PubMed 16 Nov 2026

Those 30 are all about one subject.

  • Antibody Therapeutic Development

    Antibody Therapeutic Development spans discovery, molecular design, formulation, analytical characterization, delivery, and clinical use. Recurring priorities are stability, aggregation, charge heterogeneity, syringe adsorption, concentration accuracy, and intravenous-to-subcutaneous transition. Other work tests antiviral combinations, neutralizing antibodies, allergen blockade, antibody-drug conjugates, and seasonal or preventive treatment. The set is unified by optimizing or evaluating antibody-based interventions, but it does not support a single disease-specific trend.

    30 papers

NEW DIRECTION

A monoclonal antibody can function as an antibiotic-resistance–reversal adjunct rather than as a standalone antimicrobial

The global epidemic carbapenem-resistant Acinetobacter baumannii model treated C32 as a neutralizing antibody against the extracellular resistance enzyme OXA23, and found that it inhibited carbapenem hydrolysis, lowered meropenem MICs in a co-culture model, and restored carbapenem susceptibility 42376991Jun. This gives the antibody a role not otherwise represented in the set: disabling a pathogen’s resistance mechanism to re-enable an existing antibiotic, rather than directly killing the pathogen, delivering a cytotoxic payload, or serving as a conventional antiviral, anti-inflammatory, or diagnostic binder.

Papers

The 30 papers from the last 6 months that study monoclonal antibody directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Antibody Therapeutic Development (30)
  1. Decision-Making About Respiratory Syncytial Virus Immunization for Infants: Qualitative Interview Study. JMIR formative research · 9 Nov 2026 PMID 43002700
  2. Monoclonal Antibody Coformulations Reveal Three Interaction Patterns Governing Stability. Molecular pharmaceutics · 2 Nov 2026 PMID 42969742
  3. Predictors of Antiamyloid Medication Utilization and Adherence Among People With Alzheimer Disease and Mild Cognitive Impairment. Neurology · 15 Oct 2026 PMID 42879726
  4. Deciphering complex charge heterogeneity in a glycosylated monoclonal antibody by integrated icIEF-MS and enzymatic digestion system. Journal of chromatography. A · 1 Oct 2026 PMID 42822191
  5. Practical Pipetting Optimization Strategies for Accurate Concentration Measurement of High-Concentration Protein Formulations. AAPS PharmSciTech · 23 Sept 2026 PMID 42778828
  6. Benchmarking Automated Mass Photometry against SEC-MALS and AUC for Quantifying Cross-Linked Monoclonal Antibody Aggregates. The AAPS journal · 22 Sept 2026 PMID 42768232
  7. Electrostatic and hydrophobic contributions to monoclonal antibody adsorption on prefilled syringes: a screening approach using zeta potential and dynamic streaming potential analysis. International journal of pharmaceutics · 17 Sept 2026 PMID 42754062
  8. A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology. International journal of technology assessment in health care · 17 Sept 2026 PMID 42750487
  9. Characterization of a monoclonal antibody recognizing a conserved linear neutralizing epitope of pseudorabies virus gB protein. Archives of microbiology · 11 Sept 2026 PMID 42726283
  10. 5C psychological antecedents of vaccine hesitancy toward maternal RSV vaccines and infant monoclonal antibodies among pregnant and postpartum women and their partners in China: A multicenter, dyadic survey design, cross-sectional study. Human vaccines & immunotherapeutics · 9 Sept 2026 PMID 42714313
  11. Comparative evaluation of screening approaches for antiviral monoclonal antibody combinations. Journal of virology · 2 Sept 2026 PMID 42684896
  12. Human monoclonal antibodies targeting α-Gal restrict IgE engagement of α-Gal syndrome allergens. The Journal of clinical investigation · 1 Sept 2026 PMID 42677844
  13. DyAb: sequence-based antibody design and property prediction in a low-data regime. mAbs · 28 Aug 2026 PMID 42665538
  14. SHR-A2102, a nectin-4 directed antibody-drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial. The Lancet. Oncology · 24 Aug 2026 PMID 42636836
  15. A short-course and season-oriented Stapokibart strategy for moderate-to-severe seasonal allergic rhinitis: Real-world evidence from Northern China. The World Allergy Organization journal · 20 Aug 2026 PMID 42621997
  16. Unexpected Reactivity of 1,3,4-Thiadiazole-N-oxides with Strained Alkynes Enables Enhanced Antibody Loading. Journal of the American Chemical Society · 20 Aug 2026 PMID 42619102
  17. Development of therapeutic PD-1 monoclonal antibodies for treatment of canine tumor. Veterinary immunology and immunopathology · 11 Aug 2026 PMID 42580049
  18. Engineering High-Performance Inhalable Monoclonal Antibody Powders via Spray Freeze Drying. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 3 Aug 2026 PMID 42546983
  19. Construction of a translational whole-body physiologically based pharmacokinetic model to investigate the biodistribution of lipid nanoparticle-based mRNA therapeutics for intracellular protein targets. Journal of pharmacokinetics and pharmacodynamics · 29 Jul 2026 PMID 42527729
  20. Relaxation Processes in Freeze-Dried Monoclonal Antibody-Sucrose Formulations: The Role of Water Content. Molecular pharmaceutics · 27 Jul 2026 PMID 42504521
  21. Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. The lancet. Gastroenterology & hepatology · 16 Jul 2026 PMID 42462750
  22. Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. The lancet. Gastroenterology & hepatology · 16 Jul 2026 PMID 42462749
  23. Application of FT-IR spectroscopy as a non-invasive multi-attribute monitoring platform for critical quality attributes in monoclonal antibodies. Analytical methods : advancing methods and applications · 10 Jul 2026 PMID 42429162
  24. Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody. Acta biomaterialia · 30 Jun 2026 PMID 42379548
  25. A monoclonal antibody targeting OXA23 restores carbapenem susceptibility in global epidemic carbapenem-resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy · 30 Jun 2026 PMID 42376991
  26. Development of a novel humanized monoclonal antibody and efficacy profiling of site-directed antibody-drug conjugates for precision targeted therapy of CLDN18.2-positive cancers. Bioorganic chemistry · 28 Jun 2026 PMID 42365672
  27. Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. Inflammatory bowel diseases · 27 Jun 2026 PMID 42364076
  28. QC friendly polysorbate quantification in high concentration protein samples. Journal of pharmaceutical and biomedical analysis · 26 Jun 2026 PMID 42361487
  29. Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica. The New England journal of medicine · 3 Jun 2026 PMID 42234540
  30. Development of a VL domain antibody for congeneric detection of cobra (Naja spp.) venom. Toxicon : official journal of the International Society on Toxinology · 20 May 2026 PMID 42162763

By study type

Clinical trials (4)
  1. SHR-A2102, a nectin-4 directed antibody-drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial. The Lancet. Oncology · 24 Aug 2026 PMID 42636836
  2. Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. The lancet. Gastroenterology & hepatology · 16 Jul 2026 PMID 42462750
  3. Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. The lancet. Gastroenterology & hepatology · 16 Jul 2026 PMID 42462749
  4. Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica. The New England journal of medicine · 3 Jun 2026 PMID 42234540
Observational studies and case reports (1)
  1. 5C psychological antecedents of vaccine hesitancy toward maternal RSV vaccines and infant monoclonal antibodies among pregnant and postpartum women and their partners in China: A multicenter, dyadic survey design, cross-sectional study. Human vaccines & immunotherapeutics · 9 Sept 2026 PMID 42714313
Human data, design not indexed (5)
  1. Decision-Making About Respiratory Syncytial Virus Immunization for Infants: Qualitative Interview Study. JMIR formative research · 9 Nov 2026 PMID 43002700
  2. Predictors of Antiamyloid Medication Utilization and Adherence Among People With Alzheimer Disease and Mild Cognitive Impairment. Neurology · 15 Oct 2026 PMID 42879726
  3. Benchmarking Automated Mass Photometry against SEC-MALS and AUC for Quantifying Cross-Linked Monoclonal Antibody Aggregates. The AAPS journal · 22 Sept 2026 PMID 42768232
  4. A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology. International journal of technology assessment in health care · 17 Sept 2026 PMID 42750487
  5. DyAb: sequence-based antibody design and property prediction in a low-data regime. mAbs · 28 Aug 2026 PMID 42665538
Preclinical: animal, cell and lab studies (19)
  1. Monoclonal Antibody Coformulations Reveal Three Interaction Patterns Governing Stability. Molecular pharmaceutics · 2 Nov 2026 PMID 42969742
  2. Deciphering complex charge heterogeneity in a glycosylated monoclonal antibody by integrated icIEF-MS and enzymatic digestion system. Journal of chromatography. A · 1 Oct 2026 PMID 42822191
  3. Practical Pipetting Optimization Strategies for Accurate Concentration Measurement of High-Concentration Protein Formulations. AAPS PharmSciTech · 23 Sept 2026 PMID 42778828
  4. Electrostatic and hydrophobic contributions to monoclonal antibody adsorption on prefilled syringes: a screening approach using zeta potential and dynamic streaming potential analysis. International journal of pharmaceutics · 17 Sept 2026 PMID 42754062
  5. Characterization of a monoclonal antibody recognizing a conserved linear neutralizing epitope of pseudorabies virus gB protein. Archives of microbiology · 11 Sept 2026 PMID 42726283
  6. Comparative evaluation of screening approaches for antiviral monoclonal antibody combinations. Journal of virology · 2 Sept 2026 PMID 42684896
  7. Human monoclonal antibodies targeting α-Gal restrict IgE engagement of α-Gal syndrome allergens. The Journal of clinical investigation · 1 Sept 2026 PMID 42677844
  8. Unexpected Reactivity of 1,3,4-Thiadiazole-N-oxides with Strained Alkynes Enables Enhanced Antibody Loading. Journal of the American Chemical Society · 20 Aug 2026 PMID 42619102
  9. Development of therapeutic PD-1 monoclonal antibodies for treatment of canine tumor. Veterinary immunology and immunopathology · 11 Aug 2026 PMID 42580049
  10. Engineering High-Performance Inhalable Monoclonal Antibody Powders via Spray Freeze Drying. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 3 Aug 2026 PMID 42546983
  11. Construction of a translational whole-body physiologically based pharmacokinetic model to investigate the biodistribution of lipid nanoparticle-based mRNA therapeutics for intracellular protein targets. Journal of pharmacokinetics and pharmacodynamics · 29 Jul 2026 PMID 42527729
  12. Relaxation Processes in Freeze-Dried Monoclonal Antibody-Sucrose Formulations: The Role of Water Content. Molecular pharmaceutics · 27 Jul 2026 PMID 42504521
  13. Application of FT-IR spectroscopy as a non-invasive multi-attribute monitoring platform for critical quality attributes in monoclonal antibodies. Analytical methods : advancing methods and applications · 10 Jul 2026 PMID 42429162
  14. Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody. Acta biomaterialia · 30 Jun 2026 PMID 42379548
  15. A monoclonal antibody targeting OXA23 restores carbapenem susceptibility in global epidemic carbapenem-resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy · 30 Jun 2026 PMID 42376991
  16. Development of a novel humanized monoclonal antibody and efficacy profiling of site-directed antibody-drug conjugates for precision targeted therapy of CLDN18.2-positive cancers. Bioorganic chemistry · 28 Jun 2026 PMID 42365672
  17. Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. Inflammatory bowel diseases · 27 Jun 2026 PMID 42364076
  18. QC friendly polysorbate quantification in high concentration protein samples. Journal of pharmaceutical and biomedical analysis · 26 Jun 2026 PMID 42361487
  19. Development of a VL domain antibody for congeneric detection of cobra (Naja spp.) venom. Toxicon : official journal of the International Society on Toxinology · 20 May 2026 PMID 42162763
Unclassified: not yet indexed with MeSH (1)
  1. A short-course and season-oriented Stapokibart strategy for moderate-to-severe seasonal allergic rhinitis: Real-world evidence from Northern China. The World Allergy Organization journal · 20 Aug 2026 PMID 42621997